{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T01:05:54Z","timestamp":1648688754888},"reference-count":0,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Rep"],"DOI":"10.3892\/or.2011.1502","type":"journal-article","created":{"date-parts":[[2011,10,12]],"date-time":"2011-10-12T10:33:06Z","timestamp":1318415586000},"source":"Crossref","is-referenced-by-count":2,"title":["Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia"],"prefix":"10.3892","author":[{"given":"Jianmin","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2011,10,12]]},"container-title":["Oncology Reports"],"original-title":[],"link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2011.1502\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T09:06:09Z","timestamp":1493283969000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/or.2011.1502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,12]]},"references-count":0,"URL":"https:\/\/doi.org\/10.3892\/or.2011.1502","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,12]]}}}